glp 1 fda compounding ban issued 25 warning letters to telehealth companies for false and misleading Compounded GLP-1s are entering a

In clinical studies, a greater number of people who took Saxenda for 56 weeks lost 5 to 10% of their body weight, compared with people who took a placebo

Curious about what type of gut you have

In 2022, the FDA placed BPC-157 on its list of bulk drug substances that may not be used in compounding under Section 503A, though enforcement actions have varied by jurisdiction [5]

The metabolic changes these drugs create can still affect your eyes

In preclinical heart-failure models, elamipretide improved left ventricular function and attenuated remodeling

"Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency"